Staar Surgical (STAA) Fundamental Analysis: Revenue, Earnings & Valuation

0.86 / 10

Underperform

Fundamental analysis rates STAA as Underperform, with a challenging profile. Profit‑to‑market‑value is modestly positive, while cash‑to‑market‑value and profitability ratios are negative, indicating weak cash position and low returns on assets. Overall fundamentals appear strained.

Analysis Checks(2/10)

Revenue-MV

Value-0.65

Score2/3

Weight-25.82%

1M Return1.21%

ROA (%)

Value-16.74

Score1/3

Weight16.96%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value-14.30

Score1/3

Weight26.74%

1M Return-1.35%

Profit-MV

Value0.40

Score2/3

Weight-76.84%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-16.74

Score1/3

Weight16.96%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-36.27

Score1/3

Weight15.12%

1M Return-0.83%

Asset-MV

Value-0.49

Score1/3

Weight-8.20%

1M Return0.38%

Net profit / Total operating revenue (%)

Value-33.60

Score1/3

Weight17.27%

1M Return-0.84%

Cash-MV

Value-2.76

Score1/3

Weight72.84%

1M Return-4.16%

Net profit / Total profit (%)

Value97.79

Score1/3

Weight44.99%

1M Return-2.39%

Is STAA undervalued or overvalued?

STAA scores 0.86/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -33.60% net margin, -11.01 P/E ratio, 2.57 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.